Piramal Enterprises Ltd
NSE:PEL
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
754.2
1 122.65
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Piramal Enterprises Ltd
Cost of Revenue
Piramal Enterprises Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Piramal Enterprises Ltd
NSE:PEL
|
Cost of Revenue
-â‚ą48.3B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-14%
|
||
Housing and Urban Development Corporation Ltd
NSE:HUDCO
|
Cost of Revenue
-â‚ą20.1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
||
REC Limited
NSE:RECLTD
|
Cost of Revenue
-â‚ą321.7B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
||
Power Finance Corporation Ltd
NSE:PFC
|
Cost of Revenue
-â‚ą1.4B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
||
Indian Railway Finance Corp Ltd
NSE:IRFC
|
Cost of Revenue
-â‚ą2m
|
CAGR 3-Years
7%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
||
I
|
Indian Renewable Energy Development Agency Ltd
NSE:IREDA
|
Cost of Revenue
-â‚ą30.4B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
Piramal Enterprises Ltd
Glance View
Piramal Enterprises Ltd. engages in the business of pharmaceuticals and provision of financial services. The company is headquartered in Mumbai, Maharashtra and currently employs 13,561 full-time employees. PEL’s financial services offer a range of financial products and solutions, with wholesale and retail financing. The wholesale lending business provides financing to real estate developers, as well as corporate. Within retail lending, PEL is engaged in building a multi-product platform and offers home loans, loans for small businesses and loans for working capital to its customers. The firm offers India Resurgence Fund (IndiaRF), the distressed asset investing platform, which invests in equity and/or debt across non-real estate sectors. Its financial services also include alternative assets and investments in Shriram Group. PEL has a differentiated business model that is diversified across three segments: Contract Development and Manufacturing Organization (CDMO), Complex Hospital Generics (CHG), and India Consumer Healthcare.
See Also
What is Piramal Enterprises Ltd's Cost of Revenue?
Cost of Revenue
-48.3B
INR
Based on the financial report for Sep 30, 2024, Piramal Enterprises Ltd's Cost of Revenue amounts to -48.3B INR.
What is Piramal Enterprises Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-14%
Over the last year, the Cost of Revenue growth was -19%. The average annual Cost of Revenue growth rates for Piramal Enterprises Ltd have been -28% over the past three years , -25% over the past five years , and -14% over the past ten years .